• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强制表达 Fox-P3 可以提高工程化调节性 T 细胞的安全性和抗原特异性功能。

Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells.

机构信息

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Royal Free Hospital, London, UK; Quell Therapeutics, 84 Wood Lane, London, UK.

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Royal Free Hospital, London, UK.

出版信息

J Autoimmun. 2022 Oct;132:102888. doi: 10.1016/j.jaut.2022.102888. Epub 2022 Aug 29.

DOI:10.1016/j.jaut.2022.102888
PMID:36049437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10570926/
Abstract

Regulatory T cells (Treg) are potent inhibitors of autoreactive T cells. The intracellular transcription factor FoxP3 controls the expression levels of a diverse set of genes and plays a critical role in programming functional Tregs. Although, antigen-specific Tregs are more potent than polyclonal Tregs in treating ongoing autoimmunity, phenotype plasticity associated with loss of FoxP3 expression in Tregs can lead to the conversion into antigen-specific effector T cells which might exacerbate autoimmune pathology. In this study, we designed a retroviral vector driving the expression of FoxP3 and a human HLA-DR-restricted TCR from the same promoter. Transduction of purified human Tregs revealed that all TCR-positive cells had elevated levels of FoxP3 expression, increased CD25 and CTLA4 expression and potent suppressive function. Elevated FoxP3 expression did not impair the in vitro expansion of engineered Tregs. Adoptive transfer into HLA-DR transgenic mice revealed that FoxP3+TCR engineered Tregs showed long-term persistence with stable FoxP3 and TCR expression. In contrast, adoptive transfer of Tregs engineered with TCR only resulted in the accumulation of TCR-positive, FoxP3-negative T cells which displayed antigen-specific effector function when stimulated with the TCR-recognised peptides. Our data indicate that forced expression of FoxP3 can prevent accumulation of antigen-specific effector T cells without impairing the engraftment and persistence of engineered Tregs.

摘要

调节性 T 细胞(Treg)是自身反应性 T 细胞的有效抑制剂。胞内转录因子 FoxP3 控制着一组多样化基因的表达水平,在编程功能性 Treg 中发挥着关键作用。尽管抗原特异性 Treg 在治疗正在进行的自身免疫方面比多克隆 Treg 更有效,但 Treg 中 FoxP3 表达的丧失与表型可塑性相关,可能导致转化为抗原特异性效应 T 细胞,从而加剧自身免疫病理。在这项研究中,我们设计了一种逆转录病毒载体,该载体从同一启动子驱动 FoxP3 和人类 HLA-DR 限制性 TCR 的表达。对纯化的人 Treg 的转导表明,所有 TCR 阳性细胞的 FoxP3 表达水平升高,CD25 和 CTLA4 表达增加,且具有强大的抑制功能。FoxP3 表达水平的升高并未损害工程 Treg 的体外扩增。将其过继转移到 HLA-DR 转基因小鼠中表明,FoxP3+TCR 工程化 Treg 具有长期持久性,FoxP3 和 TCR 表达稳定。相比之下,过继转移仅用 TCR 工程化的 Treg 会导致 TCR 阳性、FoxP3 阴性 T 细胞的积累,当用 TCR 识别的肽刺激时,这些细胞会显示出抗原特异性效应功能。我们的数据表明,强制表达 FoxP3 可以防止抗原特异性效应 T 细胞的积累,而不会损害工程化 Treg 的植入和持久性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/3e131cd20383/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/724e0f6d607a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/0e15e7dd7634/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/c03b8db5853e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/c924a7221879/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/3e131cd20383/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/724e0f6d607a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/0e15e7dd7634/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/c03b8db5853e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/c924a7221879/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7d/10570926/3e131cd20383/gr5.jpg

相似文献

1
Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells.强制表达 Fox-P3 可以提高工程化调节性 T 细胞的安全性和抗原特异性功能。
J Autoimmun. 2022 Oct;132:102888. doi: 10.1016/j.jaut.2022.102888. Epub 2022 Aug 29.
2
Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.工程化的 MBP 特异性人 Tregs 通过 IL-2 触发的效应 T 细胞抑制改善 MOG 诱导的 EAE。
J Autoimmun. 2018 Aug;92:77-86. doi: 10.1016/j.jaut.2018.05.003. Epub 2018 May 30.
3
Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function.人类 HLA-DR+CD27+ 调节性 T 细胞表现出增强的抗原特异性抑制功能。
JCI Insight. 2023 Dec 8;8(23):e162978. doi: 10.1172/jci.insight.162978.
4
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.在人源性 CAR-Treg 中过表达 FOXP3 可提高 CAR-Treg 产品的稳定性、疗效和安全性,使其更适合临床应用。
J Autoimmun. 2023 Jul;138:103057. doi: 10.1016/j.jaut.2023.103057. Epub 2023 May 23.
5
Human LAPGARPFOXP3 regulatory T cells attenuate xenogeneic graft versus host disease.人源 LAPGARPFOXP3 调节性 T 细胞可减轻异种移植物抗宿主病。
Theranostics. 2019 Apr 12;9(8):2315-2324. doi: 10.7150/thno.30254. eCollection 2019.
6
Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.表达RORγt的Foxp3(+) T细胞代表一种稳定的调节性T细胞效应谱系,在肠道炎症期间具有增强的抑制能力。
Mucosal Immunol. 2016 Mar;9(2):444-57. doi: 10.1038/mi.2015.74. Epub 2015 Aug 26.
7
Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.工程化共表达 MHC Ⅱ类:肽复合物的调节性 T 细胞是有效的自身免疫性 T 细胞功能抑制剂,并可预防自身免疫性关节炎的发生。
J Immunol. 2013 Jun 1;190(11):5382-91. doi: 10.4049/jimmunol.1300024. Epub 2013 Apr 29.
8
Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.外周耐受中的Th3细胞。I. 源自转化生长因子-β T细胞转基因小鼠的Th3细胞诱导Foxp3阳性调节性T细胞
J Immunol. 2007 Jan 1;178(1):179-85. doi: 10.4049/jimmunol.178.1.179.
9
A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4 CD25 FOXP3 Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition.GMCSF-神经抗原耐受疫苗在髓鞘特异性 TCR 转基因小鼠中诱导全身性 CD4 CD25 FOXP3 调节性 T 细胞淋巴细胞增多,这取决于低效率的 T 细胞抗原受体识别。
Front Immunol. 2019 Jan 10;9:3119. doi: 10.3389/fimmu.2018.03119. eCollection 2018.
10
Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells.用工程化双特异性Foxp3 +调节性CD4 + T细胞治疗实验性自身免疫性脑脊髓炎
J Autoimmun. 2020 Mar;108:102401. doi: 10.1016/j.jaut.2020.102401. Epub 2020 Jan 13.

引用本文的文献

1
Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?肾移植中的调节性T细胞:细胞治疗的未来?
Antibodies (Basel). 2025 Jun 17;14(2):49. doi: 10.3390/antib14020049.
2
Regulatory T cell therapies to treat autoimmune diseases and transplant rejection.用于治疗自身免疫性疾病和移植排斥反应的调节性T细胞疗法。
Nat Immunol. 2025 Jun;26(6):819-824. doi: 10.1038/s41590-025-02154-2.
3
Harnessing the biology of regulatory T cells to treat disease.利用调节性T细胞的生物学特性治疗疾病。

本文引用的文献

1
CD4FOXP3 Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation.CD4FOXP3 调节性 T 细胞疗法在 HLA 单倍体造血移植中的应用。
Front Immunol. 2019 Dec 17;10:2901. doi: 10.3389/fimmu.2019.02901. eCollection 2019.
2
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier.调节性 T 细胞治疗自身免疫和炎症性疾病:下一个前沿。
J Allergy Clin Immunol. 2018 Dec;142(6):1710-1718. doi: 10.1016/j.jaci.2018.10.015. Epub 2018 Oct 25.
3
Pathological conversion of regulatory T cells is associated with loss of allotolerance.
Nat Rev Drug Discov. 2025 Feb;24(2):93-111. doi: 10.1038/s41573-024-01089-x. Epub 2024 Dec 16.
4
Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction.移植物特异性调节性 T 细胞诱导长期、局部耐受。
Cells. 2024 Jul 19;13(14):1216. doi: 10.3390/cells13141216.
5
Targeted Therapy of Multiple Sclerosis: A Case for Antigen-Specific Tregs.多发性硬化症的靶向治疗:抗原特异性 Tregs 的案例。
Cells. 2024 May 8;13(10):797. doi: 10.3390/cells13100797.
6
Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?自身免疫中的平衡倾斜:调节性T细胞是病因、疗法,还是两者皆是?
Mol Cell Pediatr. 2024 Mar 20;11(1):3. doi: 10.1186/s40348-024-00176-8.
7
Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy.下一代调节性T细胞过继性免疫疗法的前景与风险
Cancers (Basel). 2023 Dec 17;15(24):5877. doi: 10.3390/cancers15245877.
8
knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products.用于调节性T细胞样细胞产品临床前安全性和有效性评估的基因敲除人源化小鼠模型。
Mol Ther Methods Clin Dev. 2023 Nov 7;31:101150. doi: 10.1016/j.omtm.2023.101150. eCollection 2023 Dec 14.
9
Synthetic Cell-Based Immunotherapies for Neurologic Diseases.基于合成细胞的神经疾病免疫疗法。
Neurol Neuroimmunol Neuroinflamm. 2023 Jun 29;10(5). doi: 10.1212/NXI.0000000000200139. Print 2023 Sep.
调节性 T 细胞的病理性转化与获得性免疫耐受的丧失有关。
Sci Rep. 2018 May 4;8(1):7059. doi: 10.1038/s41598-018-25384-x.
4
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.开发体外扩增的CD45RA+调节性T细胞作为克罗恩病的过继性细胞疗法。
Gut. 2016 Apr;65(4):584-94. doi: 10.1136/gutjnl-2014-306919. Epub 2015 Feb 24.
5
Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.CD45RA - Foxp3hi记忆调节性T细胞在临床肾移植耐受中的核心作用
J Am Soc Nephrol. 2015 Aug;26(8):1795-805. doi: 10.1681/ASN.2014050480. Epub 2015 Jan 2.
6
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse.HLA 单倍体相合移植联合调节性和常规 T 细胞过继免疫疗法可预防急性白血病复发。
Blood. 2014 Jul 24;124(4):638-44. doi: 10.1182/blood-2014-03-564401. Epub 2014 Jun 12.
7
Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice.体外扩增的人调节性T细胞通过抑制CD34 +干细胞重建的NOD - scid IL2rγnull小鼠中胰岛来源的单核细胞趋化蛋白-1的产生来延迟胰岛移植排斥反应。
PLoS One. 2014 Mar 3;9(3):e90387. doi: 10.1371/journal.pone.0090387. eCollection 2014.
8
Donor-specific regulatory T cells generated on donor B cells are superior to CD4+CD25high cells in controlling alloimmune responses in humanized mice.在供体B细胞上产生的供体特异性调节性T细胞在控制人源化小鼠的同种免疫反应方面优于CD4+CD25高表达细胞。
Transplant Proc. 2013 Jun;45(5):1832-7. doi: 10.1016/j.transproceed.2013.01.073.
9
Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.具有同种异体抗原特异性的人调节性 T 细胞比多克隆调节性 T 细胞更能抑制同种异体皮肤移植物损伤。
Sci Transl Med. 2011 May 18;3(83):83ra42. doi: 10.1126/scitranslmed.3002076.
10
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.过继性治疗采用重定向的初始调节性 T 细胞可导致关节炎的抗原特异性抑制。
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19078-83. doi: 10.1073/pnas.0907396106. Epub 2009 Nov 2.